prescribe semaglutide Prescription Microdose GLP-1 — Zera Health
Description
The majority of patients seeking GLP-1s present with one or more of the following: Insulin resistance or prediabetes PCOS or hormonal dysregulation Thyroid dysfunction Perimenopause-related metabolic changes Metabolic syndrome with multiple cardiovascular risk factors A platform that treats weight as the only relevant variable will miss most of these
That kind of deficit creates real risks if your food choices are poor
Clinically, semaglutide is prescribed for several conditions: Type 2 diabetes Obesity and chronic weight management Metabolic disorders involving insulin resistance The drug itself is identical across different brand names, but approved for different purposes
The drug slows down your stomach, which affects how your body absorbs the pill
PMID 34706925
Post-12 months : Maintenance phase, where you may reduce your dosage or stop the medication with lifestyle adjustments
